University scientists and advocates met in Montgomery to showcase biomedical advancements and request lawmakers work to fund research for future life-saving therapies.
Merck’s drug, molnupiravir, was found to reduce hospitalizations and deaths by 30 percent, while Pfizer's antiviral pill had a nearly 90 percent reduction.